Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Hypertension. 2014 Jun 9;64(3):465–471. doi: 10.1161/HYPERTENSIONAHA.114.03565

Table 1.

Characteristics of REGARDS study participants (n=2,043) with apparent treatment resistant hypertension stratified by number of healthy lifestyle factors.

Variable Number of Healthy Lifestyle Factors P-trend

0-1
(n=662)
2
(n=671)
3
(n=430)
4-6
(n=280)
Age (years) 66.1 ± 0.4 67.2 ± 0.4 68.7 ± 0.4 70.3 ± 0.5 <0.001
Male (%) 38.3 50.4 56.1 59.5 <0.001
Black (%) 69.7 63.7 52.9 42.5 <0.001
Education < High School (%) 24.5 19.7 17.3 8.7 <0.001
Region of residence
 Non-belt & non-buckle (%) 35.1 36.8 33.7 30.9 1 (ref)
 Residence in stroke belt (%) 22.8 18.6 22.0 18.6 0.197
 Residence in stroke buckle (%) 42.1 44.6 44.3 50.5 0.086
Diabetes (%) 53.6 47.5 39.8 32.1 <0.001
Total Cholesterol (mg/dL) 182.5 ± 1.8 181.4 ± 1.7 178.1 ± 2.0 176.2± 2.7 0.031
HDL-cholesterol (mg/dL) 48.0 ± 0.7 47.8 ± 0.6 48.1 ± 0.8 50.2 ± 1.0 0.071
eGFR< 60 ml/min1.73m2 (%) 29.1 29.4 26.2 22.3 <0.001
Albuminuria (%) 36.3 35.4 29.6 28.9 <0.001
Atrial Fibrillation (%) 17.0 15.0 14.0 15.1 0.369
Left Ventricular Hypertrophy (%) 21.7 17.0 16.3 17.7 0.128
Systolic BP (mmHg) 142.2 ± 0.8 141.7 ± 0.8 141.1 ± 1.1 143.3 ± 1.1 0.606
Diastolic BP (mmHg) 80.0 ± 0.5 79.6 ± 0.5 79.2 ± 0.6 75.0 ± 0.1 0.048
No. of antihypertensive medications 3.7 ± 0.0 3.6 ± 0.0 3.7 ± 0.0 3.6 ± 0.0 0.028
Statin use (%) 51.9 48.9 52.5 59.5 0.061
History of CHD (%) 35.2 35.3 37.0 38.7 0.508
History of stroke (%) 15.5 14.6 11.5 9.9 0.557

Data are presented as mean ± standard error or percentage.

BP, blood pressure; CHD, coronary heart disease; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein.